1. Home
  2. AIHS vs PPBT Comparison

AIHS vs PPBT Comparison

Compare AIHS & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIHS

Senmiao Technology Limited

HOLD

Current Price

$1.17

Market Cap

5.1M

Sector

Finance

ML Signal

HOLD

Logo Purple Biotech Ltd.

PPBT

Purple Biotech Ltd.

HOLD

Current Price

$0.64

Market Cap

6.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIHS
PPBT
Founded
2014
2010
Country
China
Israel
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
6.0M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
AIHS
PPBT
Price
$1.17
$0.64
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
30.8K
103.3K
Earning Date
02-13-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,560,626.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.83
$0.53
52 Week High
$17.00
$3.60

Technical Indicators

Market Signals
Indicator
AIHS
PPBT
Relative Strength Index (RSI) 48.65 43.59
Support Level $1.15 $0.58
Resistance Level $1.41 $0.73
Average True Range (ATR) 0.10 0.04
MACD 0.02 0.00
Stochastic Oscillator 35.90 47.27

Price Performance

Historical Comparison
AIHS
PPBT

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. Along with its subsidiaries, it is engaged in facilitating automobile transactions and offering related services. The group's business activities include providing car rental services to individual customers with lease term no more than twelve months; leasing and servicing of new energy vehicles; offering services to automobile purchasers throughout the purchase process; providing management and related services to Partner Platforms and other companies; automobile financing; and providing other related supporting services to customers. The majority of the group's revenue is generated from its automobile rental business.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

Share on Social Networks: